These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 27091465)

  • 1. Midori-ishi Cyan/monomeric Kusabira-Orange-based fluorescence resonance energy transfer assay for characterization of various E3 ligases.
    Otsubo R; Kim M; Lee J; Sasakawa C
    Genes Cells; 2016 Jun; 21(6):608-23. PubMed ID: 27091465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a high throughput time-resolved fluorescence resonance energy transfer assay for TRAF6 ubiquitin polymerization.
    Hong CA; Swearingen E; Mallari R; Gao X; Cao Z; North A; Young SW; Huang SG
    Assay Drug Dev Technol; 2003 Feb; 1(1 Pt 2):175-80. PubMed ID: 15090144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Screening of HECT E3 Ubiquitin Ligases Using UbFluor.
    Foote PK; Krist DT; Statsyuk AV
    Curr Protoc Chem Biol; 2017 Sep; 9(3):174-195. PubMed ID: 28910856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of approaches for screening for ubiquitin ligase inhibitors.
    Sun Y
    Methods Enzymol; 2005; 399():654-63. PubMed ID: 16338387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assays of Mdm2 ubiquitin ligase activity and other ubiquitin-utilizing enzymes for inhibitor discovery.
    Auger KR; Copeland RA; Lai Z
    Methods Enzymol; 2005; 399():701-17. PubMed ID: 16338390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approach for characterizing ubiquitin E3 ligase function.
    Marblestone JG; Suresh Kumar KG; Eddins MJ; Leach CA; Sterner DE; Mattern MR; Nicholson B
    J Biomol Screen; 2010 Dec; 15(10):1220-8. PubMed ID: 20864734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conserved structural mechanisms for autoinhibition in IpaH ubiquitin ligases.
    Chou YC; Keszei AFA; Rohde JR; Tyers M; Sicheri F
    J Biol Chem; 2012 Jan; 287(1):268-275. PubMed ID: 22065585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive ubiquitin E2 profiling of ten ubiquitin E3 ligases.
    Marblestone JG; Butt S; McKelvey DM; Sterner DE; Mattern MR; Nicholson B; Eddins MJ
    Cell Biochem Biophys; 2013 Sep; 67(1):161-7. PubMed ID: 23695783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening for inhibitors of the e3 ubiquitin ligase APC.
    Huang J; Sheung J; Dong G; Coquilla C; Daniel-Issakani S; Payan DG
    Methods Enzymol; 2005; 399():740-54. PubMed ID: 16338393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluorescence resonance energy transfer-based assay to study SUMO modification in solution.
    Bossis G; Chmielarska K; Gärtner U; Pichler A; Stieger E; Melchior F
    Methods Enzymol; 2005; 398():20-32. PubMed ID: 16275316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a high-throughput assay to identify inhibitors of the ubiquitin-conjugating enzyme UBCH10.
    Cléroux P; Voisin L; Meloche S
    SLAS Discov; 2022 Jun; 27(4):266-271. PubMed ID: 35342035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of TRAF6 as a ubiquitin ligase engaged in the ubiquitination of SopB, a virulence effector protein secreted by Salmonella typhimurium.
    Ruan HH; Li Y; Zhang XX; Liu Q; Ren H; Zhang KS; Zhao H
    Biochem Biophys Res Commun; 2014 Apr; 447(1):172-7. PubMed ID: 24704445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Strategy to Track Lysine-48 Ubiquitination by Fluorescence Resonance Energy Transfer.
    Wu K; Pan ZQ
    Methods Mol Biol; 2021; 2267():91-102. PubMed ID: 33786787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A linker strategy for trans-FRET assay to determine activation intermediate of NEDDylation cascade.
    Malik-Chaudhry HK; Saavedra A; Liao J
    Biotechnol Bioeng; 2014 Jul; 111(7):1288-95. PubMed ID: 24415255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of DTX3L inhibitors through a homogeneous FRET-based assay that monitors formation and removal of poly-ubiquitin chains.
    Vela-Rodríguez C; Scarpulla I; Ashok Y; Lehtiö L
    SLAS Discov; 2023 Dec; 28(8):365-375. PubMed ID: 37579950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of SUMO1 and ATP affinity for the SUMO E1by quantitative FRET technology.
    Wiryawan H; Dan K; Etuale M; Shen Y; Liao J
    Biotechnol Bioeng; 2015 Apr; 112(4):652-8. PubMed ID: 25333792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-throughput fluorescence resonance energy transfer (FRET)-based endothelial cell apoptosis assay and its application for screening vascular disrupting agents.
    Zhu X; Fu A; Luo KQ
    Biochem Biophys Res Commun; 2012 Feb; 418(4):641-6. PubMed ID: 22290227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring Shigella flexneri vacuolar escape by flow cytometry.
    Nothelfer K; Dias Rodrigues C; Bobard A; Phalipon A; Enninga J
    Virulence; 2011; 2(1):54-7. PubMed ID: 21317555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes.
    Kim DW; Lenzen G; Page AL; Legrain P; Sansonetti PJ; Parsot C
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):14046-51. PubMed ID: 16162672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay for ubiquitin ligase activity: high-throughput screen for inhibitors of HDM2.
    Davydov IV; Woods D; Safiran YJ; Oberoi P; Fearnhead HO; Fang S; Jensen JP; Weissman AM; Kenten JH; Vousden KH
    J Biomol Screen; 2004 Dec; 9(8):695-703. PubMed ID: 15634796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.